B. G. CHRISTENSEN

Publications

3.3K

Citations

H-Index

1960

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Theravance Biopharma (United States)

B. G. CHRISTENSEN is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, natural sciences, and medicinal chemistry.

Top concepts

PharmacologyNatural SciencesMedicinal ChemistryOrganic ChemistryBioorganic ChemistryBiochemistryChemistryMedicineEngineeringDrug Discovery

Publications per year

1960–2008

Publications

A stereocontrolled synthesis of (+)-thienamycin

T. N. SALZMANN, Ronald W. Ratcliffe, B. G. CHRISTENSEN et al. · Journal of the American Chemical Society · 1980 · 388 citations

Molecular Sciences, Bioorganic Chemistry, Natural Sciences +11

Phosphonomycin: Structure and Synthesis

B. G. CHRISTENSEN, W. J. Leanza, T. R. BEATTIE et al. · Science · 1969 · 178 citations

Medicinal Chemistry, Bioorganic Chemistry, Antibiotic Phosphonomycin +10

N-Acetimidoyl- and N-formimidoylthienamycin derivatives: antipseudomonal .beta.-lactam antibiotics

W. J. Leanza, Kenneth J. Wildonger, Thomas W. Miller et al. · Journal of Medicinal Chemistry · 1979 · 163 citations

Bioorganic Chemistry, Altmetric Attention Score, Antimicrobial Chemotherapy +16

Hydrophobic Vancomycin Derivatives with Improved ADME Properties: Discovery of Telavancin (TD-6424)

Michael R. Leadbetter, Stacy M. Adams, BETTINA BAZZINI et al. · The Journal of Antibiotics · 2004 · 163 citations · Full text

A novel synthesis of the carbapen-2-em ring system

Ronald W. Ratcliffe, T. N. SALZMANN, B. G. CHRISTENSEN · Tetrahedron Letters · 1980 · 163 citations

Carbapen-2-em Ring System, Chemistry, Heterocycle Chemistry

Rows per page

1–5 of 60